H.T. Gene Knockouts

Not long ago, scientists conducted loss-of-function experiments in mammals mostly by using antisense, dominant negative, or knockout technologies: Bind up the messenger RNA, swamp out the protein, or interrupt the gene, and then examine the phenotype. But the former two are unreliable, and tend to be inefficient even when they do work; the latter is difficult to achieve for both copies of a gene in a somatic cell. With such blunt instruments, researchers have been painstakingly disabling one ge

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

With such blunt instruments, researchers have been painstakingly disabling one gene at a time to gather information about what processes its product might be involved in. "There has been no concept of high-throughput gene knockouts in any mammalian system up to now," says David Beach, president of Cambridge, Mass.-based Genetica Inc. But Genetica is introducing that concept to the world of drug discovery with the help of a relatively new technology, RNA interference (RNAi).

First described in worms in 1998,1 RNAi operates in plants, fungi, flies, and mammals. An enzyme complex recognizes double-stranded RNA (dsRNA), and cuts it into roughly 22-nucleotide-long fragments. These fragments, termed siRNAs for "small interfering RNAs," then act as templates for the RNAi-inducing silencing complex to destroy the homologous message, thus specifically suppressing its expression. This form of RNAi is termed "post-transcriptional gene silencing," or PTGS; other forms are also thought to operate at the genomic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Josh Roberts

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo